Home › Funds › Raiffeisen Bank International AG › VRTX

Raiffeisen Bank International AG position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Raiffeisen Bank International AG reported holding 98,033 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$49.0M, representing 0.60% of its reported portfolio and ranking #39 among its reported holdings. Raiffeisen Bank International AG has disclosed VRTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)98.03K sh
Reported value held$48.98M
Portfolio Weight0.60%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Raiffeisen Bank International AG's VRTX position evolved

Raiffeisen Bank International AG first disclosed a stake in VRTX in Q4 2024 at 133,898 shares (US$53.5M). The position peaked in Q1 2025 at 131,609 shares, worth US$64.8M. Across 7 filings, Raiffeisen Bank International AG increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 98,033 shares valued at US$49.0M — a reduction of -4,265 shares quarter over quarter.. Notable position changes include a 99% trim in Q3 2025 (shares rose 16% over the following quarter), a 13053% increase in Q4 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 133.90K $53.48M New
Q1 2025 131.61K $64.84M Reduce
Q2 2025 113.93K $50.79M Reduce
Q3 2025 863 $337.99K Reduce
Q4 2025 113.51K $51.44M Add
Q1 2026 102.30K $45.34M Reduce
Q2 2026 98.03K $48.98M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Raiffeisen Bank International AG held VRTX?

Raiffeisen Bank International AG has disclosed VRTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Raiffeisen Bank International AG's current position in VRTX?

As of Q2 2026, Raiffeisen Bank International AG holds 98.03K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $48.98M, representing 0.60% of its reported portfolio and ranking #39.

Has Raiffeisen Bank International AG been buying or selling VRTX?

In the latest 13F filing (Q2 2026), Raiffeisen Bank International AG reduced its position in VRTX. The position peaked in Q1 2025 at 131.61K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.